Tag: Europe Adalimumab Market
Europe Adalimumab Market Evolves Amid Growing Biosimilar Competition
Data Bridge Market Research analyses that the market is growing with a CAGR of 16.2% in the forecast period of 2022 to 2029 and is expected to reach USD 10,337.79 million by 2029 from USD 3,485.94 million in 2021.
0
0
0
9 Jun, 08:29 AM
